BNP Paribas Asset Management
TECH icon

BNP Paribas Asset Management’s Bio-Techne TECH Stock Holding History

BNP Paribas Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479K Buy
6,776
+3,143
+87% +$170K ﹤0.01% 1302
2026
Q1 		$190K Buy
3,633
+753
+26% +$45.2K ﹤0.01% 1370
2025
Q4 		$169K Buy
2,880
+268
+10% +$16.3K ﹤0.01% 1366
2025
Q3 		$145K Sell
2,612
-59,110
-96% -$3.17M ﹤0.01% 802
2025
Q2 		$3.18M Buy
61,722
+49,301
+397% +$2.48M 0.01% 641
2025
Q1 		$728K Buy
12,421
+2,640
+27% +$179K ﹤0.01% 777
2024
Q4 		$705K Buy
9,781
+2,911
+42% +$214K ﹤0.01% 798
2024
Q3 		$549K Sell
6,870
-447
-6% -$33.6K ﹤0.01% 807
2024
Q2 		$524K Sell
7,317
-1,390
-16% -$102K ﹤0.01% 873
2024
Q1 		$613K Buy
8,707
+1,005
+13% +$71.9K ﹤0.01% 798
2023
Q4 		$594K Buy
7,702
+1,081
+16% +$71.2K ﹤0.01% 769
2023
Q3 		$451K Buy
6,621
+389
+6% +$30.7K ﹤0.01% 790
2023
Q2 		$509K Sell
6,232
-752
-11% -$60.4K ﹤0.01% 777
2023
Q1 		$518K Buy
6,984
+644
+10% +$49.6K ﹤0.01% 803
2022
Q4 		$525K Buy
6,340
+1,700
+37% +$135K ﹤0.01% 831
2022
Q3 		$329K Buy
+4,640
New +$401K ﹤0.01% 844
2022
Q1 		– Sell
-2,760
Closed -$357K – 934
2021
Q4 		$357K Buy
2,760
+64
+2% +$7.85K ﹤0.01% 853
2021
Q3 		$327K Buy
2,696
+716
+36% +$87.1K ﹤0.01% 830
2021
Q2 		$223K Buy
+1,980
New +$208K ﹤0.01% 881
2019
Q3 		– Sell
-7,908
Closed -$412K – 884
2019
Q2 		$412K Sell
7,908
-476
-6% -$24K ﹤0.01% 789
2019
Q1 		$416K Hold
8,384
– – ﹤0.01% 821
2018
Q4 		$297K Buy
8,384
+3,200
+62% +$134K ﹤0.01% 851
2018
Q3 		$265K Sell
5,184
-1,068
-17% -$47.3K ﹤0.01% 874
2018
Q2 		$231K Buy
+6,252
New +$239K ﹤0.01% 920

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BNP Paribas Asset Management's TECH Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Bio-Techne (TECH) stake by 87% in Q2 2026, buying an estimated $170K and bringing the position to 6,776 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #1302.

BNP Paribas Asset Management first reported a position in TECH in Q2 2018 and has held it in 24 quarters since. The position peaked at $3.18M in Q2 2025. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • BNP Paribas Asset Management held 6,776 shares of Bio-Techne worth $479K as of Q2 2026.
  • BNP Paribas Asset Management bought 3,143 Bio-Techne shares in Q2 2026, an estimated $170K.
  • Bio-Techne made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1302 holding.
  • BNP Paribas Asset Management first reported a position in Bio-Techne in Q2 2018 and has held it in 24 quarters since.
  • BNP Paribas Asset Management's Bio-Techne position peaked at $3.18M in Q2 2025.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.